Viewing StudyNCT03362723



Ignite Creation Date: 2024-05-06 @ 10:49 AM
Last Modification Date: 2024-10-26 @ 12:36 PM
Study NCT ID: NCT03362723
Status: COMPLETED
Last Update Posted: 2019-06-19
First Post: 2017-11-30

Brief Title: A Study to Investigate the Bioequivalence or Relative Bioavailability of Three New Idasanutlin Tablet Variants Following Oral Administration in Participants With Solid Tumors
Sponsor: Hoffmann-La Roche
Organization: Hoffmann-La Roche

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-11-27
Start Date Type: ACTUAL
Primary Completion Date: 2019-06-11
Primary Completion Date Type: ACTUAL
Completion Date: 2019-06-11
Completion Date Type: ACTUAL
First Submit Date: 2017-11-30
First Submit QC Date: November 30 2017
Study First Post Date: 2017-12-05
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-06-18
Last Update Post Date: 2019-06-19
Last Update Post Date Type: ACTUAL